Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan. Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension
Clinical trial NCT00168779 · COMPLETED
Trial details
- NCT number
- NCT00168779
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2006-07-01
- Enrollment
- 1185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.